skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hinsveiflur og heilahimnubólur og hliðstæður - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.
darunavir medical valley filmuhúðuð tafla 600 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg
sandimmun innrennslisþykkni, lausn 50 mg/ml
novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml
darunavir medical valley filmuhúðuð tafla 800 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 800 mg
metadon 2care4 tafla 20 mg
2care4 generics aps - methadonum hýdróklóríð - tafla - 20 mg
fesoterodine teva forðatafla 4 mg
teva b.v.* - fesoterodinum fúmarat - forðatafla - 4 mg
metronidazol actavis filmuhúðuð tafla 500 mg
actavis group ptc ehf. - metronidazolum inn - filmuhúðuð tafla - 500 mg
metronidazol actavis filmuhúðuð tafla 250 mg
actavis group ptc ehf. - metronidazolum inn - filmuhúðuð tafla - 250 mg
certican tafla 0,75 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,75 mg
certican tafla 0,5 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,5 mg